Poulin I Willey I Anastopoulo Announces A Class Action Lawsuit Has Been Filed Against Lifecore Biomedical, Inc. (LFCR)

Group 1 - A class action has been filed against Lifecore Biomedical, Inc. (LFCR) for alleged misleading statements regarding its business and financial reporting during the Class Period from October 7, 2020, to March 19, 2024 [1][2] - The Complaint claims that LFCR had deficient internal controls over financial reporting, leading to inaccurate financial statements that required restatement [2] - The company's stock reportedly lost at least half its value during the Class Period due to adverse disclosures made by the Defendants [3] Group 2 - Investors who acquired LFCR securities are encouraged to contact the firm before the lead plaintiff motion deadline of September 27, 2024 [4] - The firm has extensive experience in representing public pension funds and high net-worth investors in securities class actions [5] - The firm partner has been recognized among America's Top 100 High Stakes Litigators, indicating a strong reputation in handling complex litigation cases [6]